{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:14:20Z","timestamp":1783480460407,"version":"3.55.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13320-8","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:45:21Z","timestamp":1778694321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of HIV and hepatitis B co-infection in Nigeria: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0048-9435","authenticated-orcid":false,"given":"Jephthah Yacham","family":"Bagayang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1822-892X","authenticated-orcid":false,"given":"Taagbara Jolly","family":"Abaate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9249-4463","authenticated-orcid":false,"given":"Kimbi Enoch","family":"Danbaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abueh Nukoamene","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nwachukwu","family":"Chinyere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"13320_CR1","unstructured":"World Health Organization, Regional Office for Africa (WHO AFRO). World Hepatitis Day: In Nigeria, an estimated 20 million people are chronically infected. 2018 [cited 2024 Aug 10]. Available from: https:\/\/www.afro.who.int\/news\/world-hepatitis-day-nigeria-estimated-20-million-people-are-chronically-infected."},{"issue":"10","key":"13320_CR2","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/S2468-1253(22)00201-1","volume":"7","author":"YR Im","year":"2022","unstructured":"Im YR, Jagdish R, Leith D, Kim JU, Yoshida K, Majid A, et al. Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(10):932\u201343. https:\/\/doi.org\/10.1016\/S2468-1253(22)00201-1.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"13320_CR3","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.3390\/ijerph20054142","volume":"20","author":"DB Fofana","year":"2023","unstructured":"Fofana DB, Somboro AM, Maiga M, Kampo MI, Diakit\u00e9 B, Cissoko Y, et al. Hepatitis B virus in West African children: Systematic review and meta-analysis of HIV and other factors associated with hepatitis B infection. Int J Environ Res Public Health. 2023;20(5):4142. https:\/\/doi.org\/10.3390\/ijerph20054142.","journal-title":"Int J Environ Res Public Health"},{"key":"13320_CR4","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1186\/s12879-021-06800-6","volume":"21","author":"BI Ajuwon","year":"2021","unstructured":"Ajuwon BI, Yujuico I, Roper K, Richardson A, Sheel M, Lidbury BA. Hepatitis B virus infection in Nigeria: A systematic review and meta-analysis of data published between 2010 and 2019. BMC Infect Dis. 2021;21:1120. https:\/\/doi.org\/10.1186\/s12879-021-06800-6.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"13320_CR5","first-page":"8","volume":"3","author":"IO Okonko","year":"2020","unstructured":"Okonko IO, Adewuyi SA, Omatsone C, Cookey TI. Detection of Hepatitis B Virus among HIV-positive fresh undergraduate students in Port Harcourt, Nigeria. Asian J Res Rep Gastroenterol. 2020;3(3):8\u201313.","journal-title":"Asian J Res Rep Gastroenterol"},{"key":"13320_CR6","unstructured":"Center for Disease Control and Prevention (CDC). About HIV\/AIDS. 2019 [cited 2024 Aug 10]. Available from: https:\/\/www.cdc.gov\/hiv\/basics\/whatishiv.html."},{"key":"13320_CR7","unstructured":"World Health Organization (WHO). WHO guidelines on the use of medically important antimicrobials in food-producing animals. Geneva: WHO. 2017. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241550130."},{"issue":"2","key":"13320_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/cancers15020533","volume":"15","author":"C Shen","year":"2023","unstructured":"Shen C, Jiang X, Li M, Luo Y. Hepatitis virus and hepatocellular carcinoma: recent advances. Cancers (Basel). 2023;15(2):533. https:\/\/doi.org\/10.3390\/cancers15020533.","journal-title":"Cancers (Basel)"},{"key":"13320_CR9","unstructured":"Center for Disease Control and Prevention (CDC). HIV and viral hepatitis. 2022 [cited 2024 Aug 10]. Available from: https:\/\/www.cdc.gov\/hepatitis\/populations\/hiv.htm."},{"key":"13320_CR10","unstructured":"World Health Organization (WHO). Global report on HIV\/AIDS. 2024 [cited 2024 Aug 10]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids."},{"key":"13320_CR11","unstructured":"World Health Organization (WHO). HIV and adolescents: guidance for HIV testing and counselling and care for adolescents living with HIV. Geneva: WHO. 2015. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/179870."},{"issue":"6","key":"13320_CR12","first-page":"705","volume":"43","author":"A Askari","year":"2014","unstructured":"Askari A, Hakimi H, Ahmadabadi BN, Hassanshahi G, Arababadi MK. Prevalence of hepatitis B coinfection among HIV-positive patients: Narrative review article. Iran J Public Health. 2014;43(6):705\u201312.","journal-title":"Iran J Public Health"},{"issue":"12","key":"13320_CR13","doi-asserted-by":"publisher","first-page":"e0243656","DOI":"10.1371\/journal.pone.0243656","volume":"15","author":"MA Lawal","year":"2020","unstructured":"Lawal MA, Adeniyi OF, Akintan PE, Salako AO, Omotosho OS, Temiye EO. Prevalence of and risk factors for hepatitis B and C viral coinfections in HIV-infected children in Lagos, Nigeria. PLoS ONE. 2020;15(12):e0243656. https:\/\/doi.org\/10.1371\/journal.pone.0243656.","journal-title":"PLoS ONE"},{"issue":"6","key":"13320_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1086\/521169","volume":"45","author":"SS Toussi","year":"2007","unstructured":"Toussi SS, Abadi J, Rosenberg M, Levanon D. Prevalence of hepatitis B and C virus infections in children infected with HIV. Clin Infect Dis. 2007;45(6):795\u20138. https:\/\/doi.org\/10.1086\/521169.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"13320_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/QAI.0b013e3181c99226","volume":"54","author":"S Zhou","year":"2010","unstructured":"Zhou S, Zhao Y, He Y, Li H, Bulterys M, Sun X, et al. Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005\u20132009. J Acquir Immune Defic Syndr. 2010;54(2):191\u20136. https:\/\/doi.org\/10.1097\/QAI.0b013e3181c99226.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"13320_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/jvh.13217","volume":"27","author":"L Platt","year":"2020","unstructured":"Platt L, French CE, McGowan CR, Sabin K, Gower E, Trickey A, McDonald B, Ong J, Stone J, Easterbrook P, Vickerman P. Prevalence and burden of HBV co-infection among people living with HIV: a global systematic review and meta\u2010analysis. J Viral Hepatitis. 2020;27(3):294\u2013315.","journal-title":"J Viral Hepatitis"},{"issue":"12","key":"13320_CR17","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S2468-1253(17)30295-9","volume":"2","author":"CW Spearman","year":"2017","unstructured":"Spearman CW, Afihene M, Ally R, Apica B, Awuku Y, Cunha L, Dusheiko G, Gogela N, Kassianides C, Kew M, Lam P. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. lancet Gastroenterol Hepatol. 2017;2(12):900\u20139.","journal-title":"lancet Gastroenterol Hepatol"},{"issue":"5 Suppl","key":"13320_CR18","doi-asserted-by":"publisher","first-page":"S138","DOI":"10.1002\/hep.22883","volume":"49","author":"CL Thio","year":"2009","unstructured":"Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology. 2009;49(5 Suppl):S138\u201345. https:\/\/doi.org\/10.1002\/hep.22883.","journal-title":"Hepatology"},{"issue":"12","key":"13320_CR19","doi-asserted-by":"publisher","first-page":"e1024","DOI":"10.1016\/j.ijid.2010.06.013","volume":"14","author":"RE Barth","year":"2010","unstructured":"Barth RE, Huijgen Q, Taljaard J, Hoepelman AI. Hepatitis B\/C and HIV in sub-Saharan Africa: An association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int J Infect Dis. 2010;14(12):e1024\u201331. https:\/\/doi.org\/10.1016\/j.ijid.2010.06.013.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"13320_CR20","doi-asserted-by":"publisher","first-page":"e0215377","DOI":"10.1371\/journal.pone.0215377","volume":"14","author":"R Boateng","year":"2019","unstructured":"Boateng R, Mutocheluh M, Dompreh A, Obiri-Yeboah D, Odame Anto E, Owusu M, et al. Sero-prevalence of hepatitis B and C viral coinfections among HIV-1-infected ART-na\u00efve individuals in Kumasi, Ghana. PLoS ONE. 2019;14(4):e0215377. https:\/\/doi.org\/10.1371\/journal.pone.0215377.","journal-title":"PLoS ONE"},{"issue":"2","key":"13320_CR21","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/hep.510300","volume":"30","author":"YF Liaw","year":"1999","unstructured":"Liaw YF, Chien RN, Yeh CT, Tsai SL, Chu CM. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy. Hepatology. 1999;30(2):567\u201372. https:\/\/doi.org\/10.1002\/hep.510300.","journal-title":"Hepatology"},{"key":"13320_CR22","volume-title":"Guidelines on HIV and Hepatitis B coinfection: Recommendations for prevention and management","author":"World Health Organization (WHO)","year":"2021","unstructured":"World Health Organization (WHO). Guidelines on HIV and Hepatitis B coinfection: Recommendations for prevention and management. Geneva: WHO; 2021."},{"key":"13320_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12872-016-0338-4","volume":"16","author":"JJ Noubiap","year":"2016","unstructured":"Noubiap JJ, Bigna JJ, Nansseu JR. Antiretroviral therapy related metabolic disorders and risk of cardiovascular disease in people living with HIV: An update. BMC Cardiovasc Disord. 2016;16:154. https:\/\/doi.org\/10.1186\/s12872-016-0338-4.","journal-title":"BMC Cardiovasc Disord"},{"key":"13320_CR24","unstructured":"UNAIDS. 2025 AIDS Targets. 2020 page 10. Available from: https:\/\/www.unaids.org\/sites\/default\/files\/2025-AIDS-Targets_en.pdf."},{"key":"13320_CR25","unstructured":"Worldometers. Nigeria population. Worldometers.info. Available from: https:\/\/www.worldometers.info\/world-population\/nigeria-population\/. Accessed 12 Aug 2025."},{"issue":"10","key":"13320_CR26","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1\u201334. https:\/\/doi.org\/10.1016\/j.jclinepi.2009.06.006.","journal-title":"J Clin Epidemiol"},{"key":"13320_CR27","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottawa Hospital Research Institute. Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"issue":"1","key":"13320_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/001316446002000104","volume":"20","author":"J Cohen","year":"1960","unstructured":"Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20(1):37\u201346.","journal-title":"Educ Psychol Meas"},{"issue":"5","key":"13320_CR29","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1037\/h0031619","volume":"76","author":"JL Fleiss","year":"1971","unstructured":"Fleiss JL. Measuring nominal scale agreement among many raters. Psychol Bull. 1971;76(5):378\u201382.","journal-title":"Psychol Bull"},{"issue":"11","key":"13320_CR30","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/jech-2013-203104","volume":"67","author":"JJ Barendregt","year":"2013","unstructured":"Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67(11):974\u20138.","journal-title":"J Epidemiol Community Health"},{"key":"13320_CR31","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1002\/hsr2.178","volume":"3","author":"L Lin","year":"2020","unstructured":"Lin L, Xu C. Arcsine-based transformations for meta-analysis of proportions: Pros, cons, and alternatives. Health Sci Rep. 2020;3:e178.","journal-title":"Health Sci Rep"},{"key":"13320_CR32","volume-title":"Introductory Statistics","author":"NA Weiss","year":"2016","unstructured":"Weiss NA. Introductory Statistics. 10th ed. Boston: Pearson; 2016.","edition":"10"},{"issue":"3","key":"13320_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2.","journal-title":"Control Clin Trials"},{"issue":"7414","key":"13320_CR34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557.","journal-title":"BMJ"},{"key":"13320_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/23259582241292511","volume":"23","author":"E Odeghe","year":"2024","unstructured":"Odeghe E, Oyeleke G, Odofin M, Duguru M, Davwar P, Nyam D, et al. Hepatitis B and C virus coinfection and their association with liver disease in persons with HIV in Nigeria. J Int Assoc Provid AIDS Care. 2024;23:1\u20138. https:\/\/doi.org\/10.1177\/23259582241292511.","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"13320_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.11604\/pamj.2013.14.89.1711","volume":"14","author":"E Nwolisa","year":"2013","unstructured":"Nwolisa E, Mbanefo F, Ezeogu J, Amadi P. Prevalence of Hepatitis B coinfection amongst HIV-infected children attending a care and treatment centre in Owerri, South-eastern Nigeria. Pan Afr Med J. 2013;14:89. https:\/\/doi.org\/10.11604\/pamj.2013.14.89.1711.","journal-title":"Pan Afr Med J"},{"key":"13320_CR37","doi-asserted-by":"publisher","first-page":"352","DOI":"10.11604\/pamj.2020.36.352.23978","volume":"36","author":"OA Adesegun","year":"2020","unstructured":"Adesegun OA, Olaniran OH, Bamidele E, Inyang JN, Adegbe M, Binuyo TO, et al. HIV-hepatitis coinfection in a rural community in Northern Nigeria. Pan Afr Med J. 2020;36:352. https:\/\/doi.org\/10.11604\/pamj.2020.36.352.23978.","journal-title":"Pan Afr Med J"},{"key":"13320_CR38","doi-asserted-by":"publisher","unstructured":"Adewole OO, Anteyi E, Ajuwon Z, Wada I, Elegba F, Ahmed P, et al. Hepatitis B and C virus co-infection in Nigerian patients with HIV infection. J Infect Dev Ctries. 2009;3(5):369\u2009\u2013\u200975. https:\/\/doi.org\/10.3855\/jidc.245. PMID: 19759507.","DOI":"10.3855\/jidc.245"},{"issue":"2","key":"13320_CR39","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.4314\/ahs.v19i2.17","volume":"19","author":"CA Omatola","year":"2019","unstructured":"Omatola CA, Idofe J, Okolo ML, Adejo PO, Maina MM, Oyiguh JA. Sero-prevalence of HBV among people living with HIV in Anyigba, Kogi State, Nigeria. Afr Health Sci. 2019;19(2):1938\u201346. https:\/\/doi.org\/10.4314\/ahs.v19i2.17.","journal-title":"Afr Health Sci"},{"issue":"1","key":"13320_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4314\/ahs.v24i1.4","volume":"24","author":"AV Opayele","year":"2024","unstructured":"Opayele AV, Arege OT, Faneye AO, Olaleye DO, Odaibo GN. Prevalence of HIV, HBV and HCV among livestock merchants and slaughterhouse workers in Ibadan, Nigeria. Afr Health Sci. 2024;24(1):16\u201324. https:\/\/doi.org\/10.4314\/ahs.v24i1.4.","journal-title":"Afr Health Sci"},{"key":"13320_CR41","doi-asserted-by":"publisher","unstructured":"Ikeako LC, Ezegwui HU, Ajah LO, Dim CC, Okeke TC. Seroprevalence of human immunodeficiency virus, hepatitis B, hepatitis C, syphilis, and co-infections among antenatal women in a tertiary institution in South East Nigeria. Ann Med Health Sci Res. 2014 Nov\u2013Dec;4(6):954\u20138. https:\/\/doi.org\/10.4103\/2141-9248.144925. PMID: 25506493; PMCID: PMC4250998.","DOI":"10.4103\/2141-9248.144925"},{"issue":"9","key":"13320_CR42","doi-asserted-by":"publisher","first-page":"e0236456","DOI":"10.1371\/journal.pone.0236456","volume":"15","author":"OA Adeyemi","year":"2020","unstructured":"Adeyemi OA, Itanyi IU, Ozigbu CE, Stadnick N, Tsuyuki K, Olayiwola O, et al. Sero-prevalence and determinants of hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria. PLoS ONE. 2020;15(9):e0236456. https:\/\/doi.org\/10.1371\/journal.pone.0236456.","journal-title":"PLoS ONE"},{"issue":"1","key":"13320_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3855\/jidc.18704","volume":"18","author":"IO Bejide","year":"2024","unstructured":"Bejide IO, Kayode TA, Ebagua AE, Obayendo OD, Mere DO, Newman AB, Obi-Odunukwe AM, Fadare AK, Ahmed MI, Adeyemi-Kayode TM, Folarin OA. Seroprevalence of Hepatitis B virus and human immunodeficiency virus co-infection in pregnant women from Osun State, Nigeria. J Infect Dev Ctries. 2024;18(1):48\u201355. https:\/\/doi.org\/10.3855\/jidc.18704.","journal-title":"J Infect Dev Ctries"},{"key":"13320_CR44","doi-asserted-by":"publisher","first-page":"100","DOI":"10.11604\/pamj.2012.12.100.1079","volume":"12","author":"TM Balogun","year":"2012","unstructured":"Balogun TM, Emmanuel S, Ojerinde EF. HIV, hepatitis B and C viruses\u2019 coinfection among patients in a Nigerian tertiary hospital. Pan Afr Med J. 2012;12:100. https:\/\/doi.org\/10.11604\/pamj.2012.12.100.1079.","journal-title":"Pan Afr Med J"},{"issue":"3","key":"13320_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.30574\/gscbps.2023.23.3.0134","volume":"23","author":"CH Ugwu","year":"2023","unstructured":"Ugwu CH, Oketah EN, Okerentugba PO, Peterside NF, Okonko IO. Serological evidence of HIV\/HBV coinfection among HIV-infected patients in Onitsha, Anambra State, Nigeria. GSC Biol Pharm Sci. 2023;23(3):1\u20138. https:\/\/doi.org\/10.30574\/gscbps.2023.23.3.0134.","journal-title":"GSC Biol Pharm Sci"},{"issue":"12","key":"13320_CR46","doi-asserted-by":"publisher","first-page":"e0243656","DOI":"10.1371\/journal.pone.0243656","volume":"15","author":"MA Lawal","year":"2020","unstructured":"Lawal MA, Adeniyi OF, Akintan PE, Salako AO, Omotosho OS, Temiye EO. Prevalence of and risk factors for hepatitis B and C viral co-infections in HIV-infected children in Lagos, Nigeria. PLoS ONE. 2020;15(12):e0243656. https:\/\/doi.org\/10.1371\/journal.pone.0243656. PMID: 33306708; PMCID: PMC7725144.","journal-title":"PLoS ONE"},{"key":"13320_CR47","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1186\/s12879-021-06368-1","volume":"21","author":"OA Adeyemi","year":"2021","unstructured":"Adeyemi OA, Mitchell A, Shutt A, Crowell TA, Ndembi N, Kokogho A, et al. Hepatitis B virus infection among men who have sex with men and transgender women living with or at risk for HIV: A cross-sectional study in Abuja and Lagos, Nigeria. BMC Infect Dis. 2021;21:654. https:\/\/doi.org\/10.1186\/s12879-021-06368-1.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"13320_CR48","doi-asserted-by":"publisher","first-page":"955","DOI":"10.4314\/ahs.v13i4.14","volume":"13","author":"EE Ikpeme","year":"2013","unstructured":"Ikpeme EE, Etukudo OM, Ekrikpo UE. Seroprevalence of HBV and HIV coinfection in children and outcomes following highly active antiretroviral therapy (HAART) in Uyo, South\u2013South Nigeria. Afr Health Sci. 2013;13(4):955\u201361. https:\/\/doi.org\/10.4314\/ahs.v13i4.14.","journal-title":"Afr Health Sci"},{"issue":"2","key":"13320_CR49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.21010\/ajid.v10i2.1","volume":"10","author":"ND Uleanya","year":"2016","unstructured":"Uleanya ND, Nwokoye IC, Emodi IJ, Obidike EO, Ikefuna AN, Eze JC, et al. The prevalence, liver function, and immunologic status of children with HIV and hepatitis B virus coinfection in Enugu, Nigeria. Afr J Infect Dis. 2016;10(2):61\u20138. https:\/\/doi.org\/10.21010\/ajid.v10i2.1.","journal-title":"Afr J Infect Dis"},{"issue":"12","key":"13320_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15321819.2021.1895218","volume":"42","author":"O Akinniyi","year":"2021","unstructured":"Akinniyi O, Adetunji S, Alawode-Obabiyi L, et al. Serological patterns of hepatitis B virus infection among people living with HIV in Ibadan, Nigeria. J Immunoass Immunochem. 2021;42(12):1\u20139. https:\/\/doi.org\/10.1080\/15321819.2021.1895218.","journal-title":"J Immunoass Immunochem"},{"issue":"1","key":"13320_CR51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/15321819.2015.1040160","volume":"37","author":"OO Opaleye","year":"2016","unstructured":"Opaleye OO, Igboama MC, Ojo JA, Odewale G. Seroprevalence of HIV, HBV, HCV, and HTLV among pregnant women in Southwestern Nigeria. J Immunoass Immunochem. 2016;37(1):29\u201342. https:\/\/doi.org\/10.1080\/15321819.2015.1040160.","journal-title":"J Immunoass Immunochem"},{"issue":"2","key":"13320_CR52","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S1665-2681(19)31872-1","volume":"7","author":"JA Otegbayo","year":"2008","unstructured":"Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S, Adewole IF, Olaleye DO, Murphy R, Kanki P. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. Ann Hepatol. 2008;7(2):152\u20136. https:\/\/doi.org\/10.1016\/S1665-2681(19)31872-1.","journal-title":"Ann Hepatol"},{"key":"13320_CR53","unstructured":"Ejele OA, Nwauche CA, Erhabor O. The prevalence of hepatitis B surface antigenaemia in HIV positive patients in the Niger Delta, Nigeria. Niger J Med. 2004 Apr-Jun;13(2):175\u20139. PMID: 15293840."},{"key":"13320_CR54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijid.2020.12.058","volume":"101","author":"FA Magaji","year":"2020","unstructured":"Magaji FA, Okolo MO, Yiltok ES, Golit W, Anzaku SA, Ogwuche J, et al. Prevalence of hepatitis B virus infection in pregnant women with and without HIV in Jos, Nigeria. Int J Infect Dis. 2020;101:73\u20139. https:\/\/doi.org\/10.1016\/j.ijid.2020.12.058.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"13320_CR55","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3126\/ije.v2i1.9206","volume":"2","author":"B Aliyu","year":"2013","unstructured":"Aliyu B, Manga B, Isa MA. Prevalence of hepatitis B virus among HIV positive patients attending Specialist Hospital Sokoto, Nigeria. Int J Environ. 2013;2(1):186\u201393. https:\/\/doi.org\/10.3126\/ije.v2i1.9206.","journal-title":"Int J Environ"},{"issue":"3","key":"13320_CR56","doi-asserted-by":"publisher","first-page":"546","DOI":"10.21608\/mid.2021.64091.1126","volume":"2","author":"M Sale","year":"2021","unstructured":"Sale M, Bagarmi A, Yunana S. Prevalence of hepatitis B virus coinfection among human immunodeficiency virus positive patients in Yola, Adamawa State, Nigeria. Microbes Infect Dis. 2021;2(3):546\u201352. https:\/\/doi.org\/10.21608\/mid.2021.64091.1126.","journal-title":"Microbes Infect Dis"},{"issue":"1b","key":"13320_CR57","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4314\/dujopas.v10i1b.17","volume":"10","author":"MM Kurawa","year":"2024","unstructured":"Kurawa MM, Abdullah T, Musa AA, Umar MD, et al. Prevalence of human immunodeficiency virus (HIV) and hepatitis B virus (HBV) coinfection among people living with HIV in Dutse Metropolis, Jigawa, Nigeria. Dutse J Pure Appl Sci. 2024;10(1b):164\u201373. https:\/\/doi.org\/10.4314\/dujopas.v10i1b.17.","journal-title":"Dutse J Pure Appl Sci"},{"issue":"2","key":"13320_CR58","first-page":"52","volume":"5","author":"IL Oboro","year":"2017","unstructured":"Oboro IL. Human immunodeficiency and hepatitis B virus coinfection in a referral hospital, Southern Nigeria. Gaz Med. 2017;5(2):52.","journal-title":"Gaz Med"},{"key":"13320_CR59","doi-asserted-by":"publisher","unstructured":"Okonko IO, Shaibu N. HIV\/HBV coinfections among people living with HIV\/AIDS in Yenagoa, Bayelsa, Nigeria. Preprint. Infectious Diseases. 2023 Mar 7. https:\/\/doi.org\/10.32388\/VWR1G1.","DOI":"10.32388\/VWR1G1"},{"issue":"2","key":"13320_CR60","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4103\/1119-3077.151790","volume":"18","author":"CK Ojide","year":"2015","unstructured":"Ojide CK, Kalu EI, Ogbaini Emevon E, Nwadike VU. Coinfections of hepatitis B and C with human immunodeficiency virus among adult patients attending human immunodeficiency virus outpatient clinic in Benin City, Nigeria. Niger J Clin Pract. 2015;18(2):217\u201321. https:\/\/doi.org\/10.4103\/1119-3077.151790.","journal-title":"Niger J Clin Pract"},{"key":"13320_CR61","unstructured":"Sadoh AE, Sadoh WE, Iduoriyekemwen NJ. HIV co-infection with hepatitis B and C viruses among Nigerian children in an antiretroviral treatment programme. S Afr J Child Health. 2011;5(1):7\u201310. Available from: https:\/\/hdl.handle.net\/10520\/EJC64802."},{"key":"13320_CR62","doi-asserted-by":"publisher","first-page":"e00985","DOI":"10.1016\/j.sciaf.2021.e00985","volume":"14","author":"UI Ugah","year":"2021","unstructured":"Ugah UI, Alo MN, Gloria UC. Epidemiology of hepatitis B virus, hepatitis C virus and human immunodeficiency virus co-infection among asymptomatic persons resident in Alex Ekwueme Federal University Ndufu-Alike. Sci Afr. 2021;14:e00985. https:\/\/doi.org\/10.1016\/j.sciaf.2021.e00985.","journal-title":"Sci Afr"},{"key":"13320_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/ijph.2025.1607655","author":"TJ Abaate","year":"2025","unstructured":"Abaate TJ, Buowari DY, Agiri UA Jr, Inimgba T, Ogbonna VI, Onyeaghala C, et al. Prevalence of COVID-19 vaccine hesitancy among healthcare workers in Nigeria: A systematic review and meta-analysis. Int J Public Health. 2025. https:\/\/doi.org\/10.3389\/ijph.2025.1607655.","journal-title":"Int J Public Health"},{"issue":"7650","key":"13320_CR64","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Sch\u00fcnemann HJ, GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136. https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD.","journal-title":"BMJ"},{"key":"13320_CR65","unstructured":"Prevalence of and. risk factors for hepatitis B and C viral co-infections in HIV-infected children in Lagos. PMC. [Online]. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7728231\/."},{"issue":"3","key":"13320_CR66","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.idh.2018.02.006","volume":"23","author":"JJ Bigna","year":"2018","unstructured":"Bigna JJ, Nkeck JR, Ngouo A, Nyaga UF, Noubiap JJ. Hepatitis B virus and HIV coinfection among adults residing in Cameroon: A systematic review and meta-analysis of prevalence studies. Infect Dis Now. 2018;23(3):170\u20138. https:\/\/doi.org\/10.1016\/j.idh.2018.02.006.","journal-title":"Infect Dis Now"},{"key":"13320_CR67","doi-asserted-by":"publisher","first-page":"1565621","DOI":"10.3389\/fpubh.2025.1565621","volume":"13","author":"M Dagnaw","year":"2025","unstructured":"Dagnaw M, Muche AA, Geremew BM, Gezie LD. Prevalence and burden of HBV\u2013HIV comorbidity: A global systematic review and meta-analysis. Front Public Health. 2025;13:1565621. https:\/\/doi.org\/10.3389\/fpubh.2025.1565621.","journal-title":"Front Public Health"},{"key":"13320_CR68","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12981-016-0107-x","volume":"5","author":"AA Agyeman","year":"2016","unstructured":"Agyeman AA, Ofori-Asenso R. Prevalence of HIV and hepatitis B coinfection in Ghana: a systematic review and meta-analysis. Infect Dis Poverty. 2016;5:23. https:\/\/doi.org\/10.1186\/s12981-016-0107-x.","journal-title":"Infect Dis Poverty"},{"key":"13320_CR69","doi-asserted-by":"publisher","first-page":"205031212110727","DOI":"10.1177\/20503121211072748","volume":"10","author":"VD Kajogoo","year":"2022","unstructured":"Kajogoo VD, Swai SS, Gurung S. Prevalence of occult hepatitis B among HIV-positive individuals in Africa: A systematic review and meta-analysis. SAGE Open Med. 2022;10:20503121211072748.","journal-title":"SAGE Open Med"},{"key":"13320_CR70","volume-title":"Nigeria HIV\/AIDS Indicator and Impact Survey (NAIIS) 2018: Final Report","author":"Federal Ministry of Health","year":"2018","unstructured":"Federal Ministry of Health. Nigeria HIV\/AIDS Indicator and Impact Survey (NAIIS) 2018: Final Report. Abuja: FMOH; 2018."},{"key":"13320_CR71","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12985-020-01404-z","volume":"17","author":"S Yu","year":"2020","unstructured":"Yu S, Yu C, Li J, Liu S, Wang H, Deng M. Hepatitis B and hepatitis C prevalence among people living with HIV\/AIDS in China: A systematic review and meta-analysis. Virol J. 2020;17:127. https:\/\/doi.org\/10.1186\/s12985-020-01404-z.","journal-title":"Virol J"},{"key":"13320_CR72","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s40249-021-00876-7","volume":"10","author":"HA Gharaei","year":"2021","unstructured":"Gharaei HA, Fararouei M, Mirzazadeh A, Sharifnia G, Rohani-Rasaf M, Bastam D, et al. The global and regional prevalence of hepatitis C and B coinfections among prisoners living with HIV: A systematic review and meta-analysis. Infect Dis Poverty. 2021;10:93. https:\/\/doi.org\/10.1186\/s40249-021-00876-7.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"13320_CR73","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/s12879-017-2695-z","volume":"17","author":"FM Tengan","year":"2017","unstructured":"Tengan FM, Abdala E, Nascimento MC, Rizk J, Barone AA. Prevalence of hepatitis B in people living with HIV\/AIDS in Latin America and the Caribbean: A systematic review and meta-analysis. BMC Infect Dis. 2017;17(1):587. https:\/\/doi.org\/10.1186\/s12879-017-2695-z.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"13320_CR74","doi-asserted-by":"publisher","first-page":"1000308","DOI":"10.4172\/2155-6113.1000308","volume":"5","author":"LF Owolabi","year":"2014","unstructured":"Owolabi LF, Ibrahim A, Musa BM, Gwaram BA, Dutse AI, Hamza M, et al. Prevalence and burden of human immunodeficiency virus and hepatitis B virus coinfection in Nigeria: A systematic review and meta-analysis. J AIDS Clin Res. 2014;5(6):1000308. https:\/\/doi.org\/10.4172\/2155-6113.1000308.","journal-title":"J AIDS Clin Res"},{"key":"13320_CR75","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1186\/s12889-024-21017-3","volume":"24","author":"OM Akabuike","year":"2024","unstructured":"Akabuike OM, Aworh MK, Uzoebo NL, Erwat J, Agukwe O, Ngong K, et al. Evaluating hepatitis B screening, prevalence, vaccination coverage, and linkage to care in Abuja, Nigeria: insights from a cross-sectional study. BMC Public Health. 2024;24:3475. https:\/\/doi.org\/10.1186\/s12889-024-21017-3. PMID: 39696217; PMCID: PMC11657572.","journal-title":"BMC Public Health"},{"key":"13320_CR76","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13690-023-01142-y","volume":"81","author":"A Issa","year":"2023","unstructured":"Issa A, Ayoola YA, Abdulkadir MB, Ibrahim RO, Oseni TIA, Abdullahi M, et al. Hepatitis B vaccination status among health workers in Nigeria: a nationwide survey between January to June 2021. Arch Public Health. 2023;81:123. https:\/\/doi.org\/10.1186\/s13690-023-01142-y.","journal-title":"Arch Public Health"},{"key":"13320_CR77","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12879-025-10554-w","volume":"25","author":"JB Alege","year":"2025","unstructured":"Alege JB, Oyore JP, Nanyonga RC, Musoke P, Orago ASS. Barriers and facilitators of integrated hepatitis B, C, and HIV screening among pregnant mothers and newborns attending maternal and newborn clinics in Koboko District, Uganda: a qualitative inquiry of providers\u2019 perspective. BMC Infect Dis. 2025;25:139. https:\/\/doi.org\/10.1186\/s12879-025-10554-w.","journal-title":"BMC Infect Dis"},{"issue":"1 Suppl","key":"13320_CR78","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.jhep.2005.11.017","volume":"44","author":"A Hatzakis","year":"2006","unstructured":"Hatzakis A, Magiorkinis E, Haida C. HBV virological assessment. J Hepatol. 2006;44(1 Suppl):S71\u20136. https:\/\/doi.org\/10.1016\/j.jhep.2005.11.017.","journal-title":"J Hepatol"},{"issue":"9349","key":"13320_CR79","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","volume":"360","author":"CL Thio","year":"2002","unstructured":"Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Mu\u00f1oz A, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. 2002;360(9349):1921\u20136. https:\/\/doi.org\/10.1016\/S0140-6736(02)11913-1.","journal-title":"Lancet"},{"issue":"9","key":"13320_CR80","doi-asserted-by":"publisher","first-page":"e9506102","DOI":"10.5812\/hepatmon-9506102","volume":"22","author":"M Fasano","year":"2022","unstructured":"Fasano M, Poliseno MC, Fiore JR, Lo Caputo S, D\u2019Arminio Monforte A, Santantonio TA. Management of chronic hepatitis B in HIV-coinfected patients. Hepat Mon. 2022;22(9):e9506102. https:\/\/doi.org\/10.5812\/hepatmon-9506102. PMID: 36146828; PMCID: PMC9506102.","journal-title":"Hepat Mon"},{"issue":"18","key":"13320_CR81","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1097\/QAD.0000000000001646","volume":"31","author":"AC Thornton","year":"2017","unstructured":"Thornton AC, Jose S, Bhagani S, Chadwick D, Dunn D, Gilson R, Main J, Nelson M, Rodger A, Taylor C, Youssef E, Leen C, Gompels M, Kegg S, Schwenk A, Sabin C, UK Collaborative HIV. Cohort (UK CHIC) steering committee. Hepatitis B, hepatitis C, and mortality among HIV-positive individuals. AIDS. 2017;31(18):2525\u201332. https:\/\/doi.org\/10.1097\/QAD.0000000000001646. PMID: 28926400; PMCID: PMC5690308.","journal-title":"AIDS"},{"issue":"2","key":"13320_CR82","doi-asserted-by":"publisher","first-page":"192","DOI":"10.5588\/ijtld.11.0831","volume":"17","author":"APG dos Santos","year":"2013","unstructured":"dos Santos APG, Pacheco AG, Staviack A, Golub JE, Chaisson RE, Rolla VC, Kritski AL, Passos SRL, de Queiroz Mello FC. Safety and effectiveness of HAART in tuberculosis-HIV co-infected patients in Brazil. Int J Tuberc Lung Dis. 2013;17(2):192\u20137. https:\/\/doi.org\/10.5588\/ijtld.11.0831. PMID: 23317954; PMCID: PMC3713776.","journal-title":"Int J Tuberc Lung Dis"},{"key":"13320_CR83","unstructured":"XE. US Dollar to Nigerian Naira conversion. 2025 [cited 2025 Jun 21]. Available from: https:\/\/www.xe.com\/currencyconverter\/convert\/?Amount=1%26From=USD%26To=NGN."},{"issue":"1","key":"13320_CR84","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/jgh.12700","volume":"30","author":"CC Wang","year":"2015","unstructured":"Wang CC, Tseng TC, Kao JH. Hepatitis B virus infection and metabolic syndrome: Fact or fiction? J Gastroenterol Hepatol. 2015;30(1):14\u201320. https:\/\/doi.org\/10.1111\/jgh.12700.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"13320_CR85","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/0300-1652.114591","volume":"54","author":"S Muhammad","year":"2013","unstructured":"Muhammad S, Sani MU, Okeahialam BN. Cardiovascular disease risk factors among HIV-infected Nigerians receiving highly active antiretroviral therapy. Niger Med J. 2013;54(3):185\u201390. https:\/\/doi.org\/10.4103\/0300-1652.114591.","journal-title":"Niger Med J"},{"issue":"8","key":"13320_CR86","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1086\/605675","volume":"49","author":"J Idoko","year":"2009","unstructured":"Idoko J, Meloni S, Muazu M, Nimzing L, Badung B, Hawkins C, et al. Impact of hepatitis B virus infection on HIV response to antiretroviral therapy in Nigeria. Clin Infect Dis. 2009;49(8):1268\u201373. https:\/\/doi.org\/10.1086\/605675.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"13320_CR87","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3892\/etm.2020.9467","volume":"21","author":"S Sun","year":"2021","unstructured":"Sun S, Yang Q, Sheng Y, Fu Y, Sun C, Deng C. Investigational drugs with dual activity against HBV and HIV (Review). Exp Ther Med. 2021;21(1):35. https:\/\/doi.org\/10.3892\/etm.2020.9467. PMID: 33262821; PMCID: PMC7690342.","journal-title":"Exp Ther Med"},{"issue":"2","key":"13320_CR88","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5281\/zenodo.8332533","volume":"13","author":"AA Alali","year":"2023","unstructured":"Alali AA, Dan-Jumbo A, Ogaji DS. Cost of managing chronic hepatitis B in a resource-poor setting; the implications for universal health coverage reform. Greener J Med Sci. 2023;13(2):155\u201363. https:\/\/doi.org\/10.5281\/zenodo.8332533.","journal-title":"Greener J Med Sci"},{"key":"13320_CR89","doi-asserted-by":"publisher","first-page":"277","DOI":"10.11604\/pamj.2020.37.277.25952","volume":"37","author":"ID Nnakenyi","year":"2020","unstructured":"Nnakenyi ID, Uchechukwu C, Nto-ezimah U. Prevalence of hepatitis B and C virus co-infection in HIV positive patients attending a health institution in southeast Nigeria. Pan Afr Med J. 2020;37:277. https:\/\/doi.org\/10.11604\/pamj.2020.37.277.25952. PMID: 33163019; PMCID: PMC7609124.","journal-title":"Pan Afr Med J"},{"issue":"5","key":"13320_CR90","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.3390\/ijerph20054142","volume":"20","author":"DB Fofana","year":"2023","unstructured":"Fofana DB, Somboro AM, Maiga M, Kampo MI, Diakit\u00e9 B, Cissoko Y, McFall SM, Hawkins CA, Maiga AI, Sylla M, Gozlan J. Hepatitis B virus in West African children: systematic review and meta-analysis of HIV and other factors associated with hepatitis B infection. Int J Environ Res Public Health. 2023;20(5):4142.","journal-title":"Int J Environ Res Public Health"},{"issue":"1337","key":"13320_CR91","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1098\/rspb.1993.0102","volume":"253","author":"WJ Edmunds","year":"1993","unstructured":"Edmunds WJ, Medley GF, Nokes DJ, Hall AJ, Whittle HC. The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci. 1993;253(1337):197\u2013201. https:\/\/doi.org\/10.1098\/rspb.1993.0102.","journal-title":"Proc Biol Sci"},{"key":"13320_CR92","unstructured":"National Agency for the Control of AIDS (NACA). Nigeria HIV\/AIDS Indicator and Impact Survey (NAIIS) 2018: Technical Report, Abuja. Nigeria: NACA; 2019. Available from: https:\/\/www.naca.gov.ng\/naiis-2018-final-report."},{"issue":"1","key":"13320_CR93","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1186\/s12889-018-5432-7","volume":"18","author":"M Lingani","year":"2018","unstructured":"Lingani M, Akita T, Ouoba S, Sanou AM, Sugiyama A, Tarnagda Z, et al. High prevalence of hepatitis B infections in Burkina Faso (1996\u20132017): a systematic review with meta-analysis of epidemiological studies. BMC Public Health. 2018;18(1):551.","journal-title":"BMC Public Health"},{"issue":"6","key":"13320_CR94","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.jhep.2019.03.009","volume":"70","author":"G Dusheiko","year":"2019","unstructured":"Dusheiko G, Lemoine M. An appraisal of the WHO hepatitis B treatment guidelines applicability to Africans. J Hepatol. 2019;70(6):1046\u20138.","journal-title":"J Hepatol"},{"key":"13320_CR95","doi-asserted-by":"crossref","unstructured":"Langan D. Assessing heterogeneity in random-effects meta-analysis. In Meta-research: methods and protocols. New York, NY: Springer US; 2021. p. 67-89.","DOI":"10.1007\/978-1-0716-1566-9_4"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13320-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13320-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13320-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:24:27Z","timestamp":1783477467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13320-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13320"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13320-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable as this study relied on publicly available data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors read and approved this manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1264"}}